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Background
Malaria is an Anopheles mosquito borne parasitic disease triggered by four species of 
genus plasmodium including P. falciparum, P. vivax, P. ovale, and P. malariae. Amongst 
these, P. falciparum is the most dangerous species because it can penetrate into deeper 
tissues and infect red blood corpuscles leading to its breakdown and rupture, forming 
sticky lump like mass structure in the blood capillary which may ground circulatory 
arrest such as cerebral attack causing death of the individual (Tham and Kennedy 2015). 
As per the updated reports approximately 3.4 billion cases of malaria occur every year 
and about 1.3 million deaths occurred in the year of 2013 worldwide (Seder 2014). Brutal 
death of more than 1 million people globally cries to develop new antimalarial chemo-
therapeutics. One of the promising antimalarial chemotherapeutics is 4-anilinoquinoline 
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derivatives including amodiaquine and piperaquine which act as blood schizontoside 
and haemazoin inhibitors. Due to drug resistance and lack of knowledge of exact mecha-
nism of action of these series of compounds, it is really urgent to design and develop new 
congeneric leads utilizing structure activity-property relationship studies. Although the 
structure–property-activity relationships were developed since long years back (Crum-
Brown and Fraser 1968), but now it is a multidisciplinary area of molecular design and 
are widely used for the prediction of properties, activities and/or toxicities of new chem-
icals by developing quantitative relationship between molecular activity or property 
(such as partition coefficient (log P), boiling point, melting point, acid and base constant, 
chromatographic retention index, toxicity, or reactivity) and computed structural prop-
erties such as constitutional, electrostatic, geometrical, topological, or quantum chemi-
cal molecular characteristics (Basak et  al. 1997; Pompe and Novic 1999; Randic 1975; 
Roy et al. 2015a, b, c). Therefore in the present paper QSAR modelling has been carried 
out for antimalarial 4-anilinoquinolines based on the computed structure–property-
activity correlations.
In this connection, a series of N1,N1-diethyl-N2-(4-quinolinyl)-1,2-ethanediamine 
derivatives having various groups substituted at the 7-position on the quinoline nucleus 
have been synthesized by Kaschula et al. (2002) who tested in vitro antimalarial activity 
of the same compounds against chloroquine sensitive D10 strain of P. falciparum show-
ing that an electron attracting group at the 7th position bears with lower pKa of both 
the quinoline nitrogen atom and the tertiary anilino nitrogen in the alkyl side chain. 
O’Neill et al. (2003) synthesized a new series of amodiaquine analogues by interchang-
ing hydroxyl at the 3′ position and the 4′ Mannich side-chain function of anilino moiety 
of quinoline which can produce non-toxic metabolite. Hwang et al. (2011) synthesized 
many 4-anilinoquinoline compounds introducing diaryl, ether, biaryl, and alkylaryl 
groups to the basic nucleus and tested their antimalarial activity against the chloroquine-
sensitive strain 3D7 and the chloroquine-resistant K1 strain as well as for cytotoxicity 
against mammalian cell lines. In vitro screening and in vivo pharmacokinetic estimation 
of virtual libraries of newly designed chloroquine scaffold based 4-anilinonoquinolines 
showed highly potent antimalarial activity in mice found out two lead compounds utiliz-
ing ADMET predictions (Ray et al. 2010). Solomon et al. (2005, 2007) synthesized new 
4-anilinoquinoline derivatives with evaluating its in  vitro activity against chloroquine 
sensitive strain of P. falciparum strain and chloroquine resistant N-67 strain of P. yoelii 
in vivo whereas the same group generated another new series of 4-anilinoquinoline ana-
logs which can form complex with hematin to act as hemazoin inhibitors showing affin-
ity towards heme polymerization target.
To predict the biochemical mechanisms of 4-anilinoquinolines, quantitative struc-
ture–property-activity relationship studies were being executed recently by many 
researchers. Gupta et  al. carried out QSAR on antimalarial activity and cytotoxicity 
of 4-anilinoquinoline using structural descriptors and identified that the antimalarial 
activity are being correlated with topological, 2D autocorrelation and functional group 
descriptors while cytotoxicity is being correlated with atom centered descriptors. This 
model suggests that the analogues with aromatic primary amines, aliphatic second-
ary amines are responsible for antimalarial activity and aromatic ethers, CH2R2 and 
CH3X contributed to cytotoxicity. With another work the author developed topological 
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descriptor based QSAR model using electrons enrich species in aniline substituent 
showing better structure activity correlations quantitatively (Gupta et  al. 2005; Gupta 
and Prabhakar 2006). Descriptors based QSAR modeling has been performed by many 
other authors and co-workers which are cited here (Masand et al. 2014; Sahu et al. 2014; 
Deshpande et al. 2009).
QSARs utilizing topological structural indices have been carried out but there is 
hardly any studies based on in silico virtual screening of combinatorial compounds and 
pharmacophore modeling of 4-anilinoquinoline compounds. One of the important tech-
niques to focus mode of binding of the ligand is pharmacophore generation when the 
crystal structure of target is unknown. Delarue et al. synthesized a number of 4-anilino-
quinolines having two proton accepting side chains and in vitro antimalarial activity has 
been evaluated on P. falciparum FcB1R strain whereas toxicity of the same compounds 
have been studied using MRC-5 cells and macrophages respectively (Delarue et al. 2001). 
A number of experimental and theoretical studies for the design of potent 4-anilinoqui-
nolines have been performing. But experimental design of a single molecule involves a 
series of reactions and processes from the starting material of synthesis, structure eluci-
dation and biological assays for activity studies. This total process consumes long years, 
enormous manpower, monetary issues and a number of animal sacrifices. So theoretical 
modeling utilizing QSAR based on topological indices computed solely from the struc-
tures of these compounds was carried out a lot. But there is scarcely any in silico design 
of 4-anilinoquinoline derivatives using pharmacophore modeling and virtual screening. 
In the present article, an attempt has been made to design thousands of combinatorial 
compounds at a time considering 4-anilinoquinoline scaffold with potential antimalar-
ial activities. Such compounds are screened for potency and selectivity utilizing high-
throughput screening techniques. HTS is based on lead optimization which incorporates 
Lipinski rule of five, QSAR and pharmacophore modeling. Such advances lead to greater 




A number of 4-anilinoquinolines having antimalarial activities against P. falciparum have 
been synthesized by Delarue et al. (2001). Different protons accepting side chains were 
substituted at 3′ and 5′ positions of the amino moiety to produce potent compounds 
which are tested for in vitro antimalarial activities against the chloroquine resistant P. 
falciparum FcB1R strain. Table 1 contains structure and antimalarial activities in terms 
of IC50 of 62 congeneric 4-anilinoquinoline derivatives. These IC50 values were con-
verted into their negative logarithms (pIC50) which are taken into consideration in the 
present calculation as dependent variables whereas computed descriptors calculated by 
using optimized 3D-structure of 4-anilinoquinoline compounds are considered as inde-
pendent variables for statistical multivariate regression modeling.
Molecular optimization is carried out by minimization of molecular surface energy. 
For this purpose, 2D structures of 4-anilinoquinolines, drawn in ChemDraw software, 
were converted into 3D modules incorporated into Chem3D Ultra (Mills 2006). The 3D 
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structures were energetically optimized using Merck Molecular Force Field with a value 
of 0.01 as Dielectric Constant.
Input MDL mol files of fully optimized molecules were then browsed into DRAGON 
software (Todeschini and Consonni et al. 2006, 2009) for computation theoretical struc-
tural descriptors. A total number of 1664 structural invariance including topological, 
3D and geometrical, constitutional and molecular property, functional group and atom 
centered fragments have been calculated. The descriptors with same or almost near val-
ues or perfectly inter-correlated were reduced from the descriptor data to improve the 
degree of freedom. Thus, after reduction, a total number of 1367 different descriptors 






































2 1 4-methyl piperidine 0.0777 1.110
3* 2 4-methyl piperidine 0.1355 0.868
4 4 4-methyl piperidine 0.4650 0.332
5 5 4-methyl piperidine 0.3045 0.516
6 7 4-methyl piperidine 0.3085 0.511
7 11 4-methyl piperidine 0.0860 1.065
8* 1 piperidine 0.0445 1.352
9 1 N-methyl piperazine 0.344 0.463
10 1 4-hydroxy piperidine 1.050 –0.021
11 1 pyrrolidine 0.0440 1.356
12 1 thiazolidine 0.5880 0.231
13* 1 NHC(CH3)3 0.0509 1.293
14 1 NEt2 0.0416 1.381
15 1 NHCH2C6H5 0.1927 0.715
16 1 NHCH2C6H4Cl(para) 0.855 0.068
17* 1 1,2,3,4-tetra hydroisoquinoline 1.450 –0.161
18 1 3-amino pyrazole 0.8065 0.093
19 0 H 0.3598 0.444
20 1 piperidine 0.0540 1.268
21 2 piperidine 0.0783 1.106
22* 4 piperidine 0.0155 1.810
23 5 piperidine 0.0274 1.562
24 7 piperidine 0.1650 0.782
25 4 pyrrolidine 0.0230 1.638
26 4 morpholine 0.0141 1.851
27 4 N-methyl piperazine 0.0651 1.186
28 4 NEt2 0.1411 0.850
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were selected for further quantitative-structure activity relationship modeling. Descrip-
tor classes along with their names and standard symbols as calculated by the DRAGON 
software are given in Additional file 1: Table S1 (Batra et al. 2015).
Statistical data analysis
The descriptor data has been analyzed by multiple linear regression (MLR) method. 
MLR can generate QSAR by correlating a set of computed structural invariance to 
compound’s antimalarial response endpoints. In the present data set sum of descrip-
tors greatly beats the number of compounds. MLR may be applied when the numbers 
of descriptors are more or lower than the number of compounds (Batra et  al. 2015; 
Table 1 continued
29 4 Br 0.1511 0.821
30 0 Phenyl 0.0755 1.122









33 - NHCH2CH2NMe2 0.0155 1.810
34 - NHCH2CH2CH2NMe2 0.134 0.873
35* - NMeCH2CH2NMe2 0.0050 2.301
36 - NHCH2CH2pyrrolidine 0.0102 1.991
37 - NHCH2CH2pyrrolidine 0.0066 2.180
38 - NHCH2CH2pyrrolidine 0.0079 2.046
39 - NEt2 0.0082 2.086
40 - NHtBu 0.0037 2.432
41 - piperidine 0.0102 1.991
42 - pyrrolidine 0.0069 2.161
43* - N-methyl piperazine 0.0075 2.125
44 - morpholine 0.0095 2.022
45 - 4-hydroxy piperidine 0.0065 2.187
46* - N-(2-hydroxy ethyl) piperazine 0.0115 1.939
47* - N-phenyl piperazine 0.0055 2.260
48* - N-benzyl piperazine 0.0130 1.886
49 - N-(diphenyl methyl) piperazine 0.0125 1.903
50 - N-(4-chloro benzyl) piperazine 0.0115 1.939
51 - N-(4-methoxy benzyl) piperazine 0.0110 1.959
52 - N-(4-nitro benzyl) piperazine 0.0132 1.879
53 - N-(4-diethyl amino benzyl) piperazine 0.0119 1.924
54 - N-(4-cyano benzyl) piperazine 0.0133 1.876
55 - N (piperonyl) piperazine 0.0069 2.161
56 - NHC6H5 0.0212 1.674
57* - NHCH2C6H5 0.0085 2.071
58 - NHCH(C6H5)2 0.0091 2.041
59 - NHCH2C6H4Cl(para) 0.0046 2.337
60 - NHCH2C6H4OMe(para) 0.0044 2.356
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Katritzky et al. 2001; Tropsha et al. 2003; Draper and Smith 1998; http://www.minitab.
com).
Since a large number of descriptor data have been calculated, so selection of variables 
is one of the decisive footsteps in QSAR modeling to predict the significant descriptors 
responsible for producing significant biological activities. If the association between the 
parameter(s) selected and activity is strong, then activity predictions will be possible. 
If there is only weak association, knowing the value of the parameter(s) will not help in 
predicting activity. Thus, for a given study, parameters should be selected which are rel-
evant to the activity for the series of molecules under investigation and these parameters 
should have values which are obtained in a consistent manner. There are a number of 
methods for descriptor selection which includes genetic algorithm (de Campos and de 
Melo 2014; Broadhurst et al. 1997), stimulated annealing (Kirkpatrick et al. 1983), step-
wise forward–backward selection (Hoskuldsson 1988; Nandi and Bagchi 2014), etc. Of 
them stepwise forward–backward feature selection is mostly user-friendly incorporated 
in Minitab software (http://www.minitab.com) which can select significant variables at 
5 % level used in the present study for the generation of a number of QSAR models uti-
lizing different sets of computed molecular descriptors including topological, 3D and 
geometrical, constitutional and molecular property, functional group and atom centered 
fragments, respectively.
F statistic value of 4.0 has been selected in the present calculation for inclusion and 
exclusion of the variables. Four different QSAR models have been formulated which 
were statistically validated by incorporating test and training sets approaches. The divi-
sion of the total data set into training and test sets was performed at a random basis. 
Compounds with asterisk mark in Table  1 were selected as test set compounds. The 
quality of training model is denoted by R2 (R is the square root of multiple R-square for 
regression) and Q2 (cross-validation R2) respectively.
R2 and Q2 of a model are calculated by
where Yobs, Ycalc and Ypred denote observed, calculated and predicted activity values, 
respectively, and Y¯ indicates mean activity value of training molecules. Q2 denotes pre-
dictive statistics which should be greater than 0.5. The validated QSAR’s can identify the 
most significant contribution of the descriptor data modeled. Such most reliable vali-
dated model can be used to predict the highly active congeneric compounds which may 
be real or virtual, generated by combinatorial library design.
Combinatorial library generation
Increase in the drug development cost and big pressure of discovering new molecules, 
pharmaceutical and biotech companies are crying to design new entity paying least 
money with increased profitability and productivity. The concept of combinatorial 
chemistry has been at the forefront of new molecule and drug discovery since 1990 
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structure-based methods (Ecker and Crooke 1995; Janda 1994; Davies 1996). However, 
one of the most efficient tools for design of millions of compounds paying least time and 
cost is computer aided combinatorial library generation. Incorporation of combinatorial 
library design and high throughput virtual screening including QSAR and pharmacoph-
ore modeling or structures based design as a major tools for lead optimization methods 
applied in the chemo-bioinformatics has dramatically altered the character of new lead 
discovery research paying least time and cost. Using traditional methods of synthesis, 
a medicinal chemist can produce limited number of compounds within certain time 
span. Early SAR studies are based on the use of physical properties and physicochemi-
cal substituent constants for the prediction of other more complex physicochemical, bio 
medicinal, and toxicological properties. Such property–property correlations are use-
ful only when such properties for all compounds are available whereas on application of 
computer aided combinatorial library design, one can generate millions of compounds 
within a few time. Most of these compounds have no physicochemical data. Hence, 
there is a need to develop QSAR models using non-empirical parameters utilizing com-
puted molecular descriptors for the screening of promising lead compound. Once high 
throughput screening started to make an impact the demand for optimized lead to test 
experimentally increased dramatically and the researchers began to develop new lead 
and scaffold more efficiently. The aim of this approach is to screen few potent lead like 
candidate structures which could be proposed for further synthesis, structure elucida-
tion and biological activity testing using synthetic experiments (Lowe 1995; Terrett et al. 
1995; Gallop et al. 1994; Nandi and Bagchi 2011a, b).
Generation of combinatorial chemical libraries is based on the designing of a scaf-
fold which is a common substructure of the congeneric series. A number of different 
aliphatic and aromatic substituents are introduced at the specified substitution points 
of the common nucleus to produce large virtual libraries. In the present article, a total 
number of 2160 compounds have been generated by introducing different substituents 
at points of diversity including R3′, R4′, R5′ and R7, respectively associated to the parent 
4-anilinoquinoline nucleus. The following Table 2 represents different possible substitu-
ents and the scaffold nucleus structures to develop combinatorial library.
Virtual compounds were then screened by the application of high throughput screen-
ing techniques comprising of validated training QSAR, pharmacophore generation 
(Marshall et al. 1979; Beusen et al. 1999; Golender et al. 1993; Vilar and Koehlar 2000) 
and Lipinski’s ‘rule of five’ (Lipinski et al. 1997), respectively. The biological activities of 
the virtual compounds were predicted using the validated training QSAR model based 
on topological indices. Although this type of activity prediction is the conventional way 
for predicting active ligands, the method is not beyond contest as we do not have experi-
mental measurement how so far the predicted activity is accurate. Therefore a compara-
tive study between the observed activity of the known amodiaquine lead and predicted 
activity of the highly active virtual compounds and mode of binding prediction through 
pharmacophore modeling has been carried out for the highly predicted active conge-
neric compounds as well as active known leads (such as amodiaquine).
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Development of pharmacophore model
A pharmacophore consists of three-dimensional structural topographies for a given 
series of diverse molecules by ensuring the interaction of molecules with the biologi-
cal target triggering the biological activity. It provides an estimate of common molec-
ular interaction capabilities of a group of bioactive compounds for its target receptor 
structure. It does not represent any molecule or a functional group (Leach et al. 2009). 
All the active molecules sharing maximum number of common features are identified 
within the conformational flexible active binding region of space (Shoichet 2004; Mason 
et al. 2001). Therefore 3D pharmacophore assumes the mode of binding of structurally 
diverse molecules towards the biological target in a possibly common binding mode. 
These features are denoted as hydrogen bond donor, hydrogen bond acceptor, hydro-
phobicity of the moiety, aromatic rings, positive ionization properties (cation), negative 
ionization properties (anion), respectively (Langer and Krovar 2003; Koes and Camacho 
2011). However, the concept is very insightful for understanding the molecular recog-
nition aspects of a target receptor shared by a set of bioactive compounds. Pharmaco-
phore modeling methods are not only useful for virtual screening and identification of 
new hits from databases but also useful for providing insights to de novo design of novel 
compounds and for understanding the complementary requirements for binding to the 
active sites of unknown candidate structures as well. Since pharmacophore transcends 
the chemical structural class and captures only the features responsible for activity, 
use of pharmacophore has the advantage for identification of potentially new biologi-
cally active compounds or chemical scaffolds as novel leads. Therefore in the present 







Substitution points Possible substituents
R3′ H , N , N , N , N , 
N , N , N NH , N , 
N
R4′
NH2 , SH , N NH , 
N N
R5′ N , N , N , N , N , 
N , N NH , N , 
N
R7 Cl , F, Br, C CH , CCl3 CF3
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study an attempt has been made to focus on the 3D structural features based pharma-
cophore generation of 4-anilinoquinolines which are active against P. falciparum FcB1R 
using Portable InteLigandScout software (version 2.02) (Wobler and Langer 2005). Being 
a fully automated and convenient software tool, Ligand Scout is widely running on all 
operating systems with works being successfully published (Schuster and Langer 2005). 
In the present study common binding mode of the congeneric active ligands was ana-
lyzed by the development of pharmacophore model considering amodiaquine lead com-
pound using default Ligand Scout settings. In addition to this pharmacophore model has 
been used as a predictive tool to optimize top 16 highly predicted active combinatorial 
compounds by generating its individual pharmacophore and compare with amodiaquine 
pharmacophore to correlate the mode of binding. Very interesting comparative predic-
tive results were found which have been discussed in the next section.
Results and discussion
QSAR modeling
Earlier publications stated that topological indices can produce maximum impact on 
antimalarial activity of these congeneric compounds (Gupta 2015; Gupta and Prabha-
kar 2006; Masand et al. 2014; Sahu et al. 2014; Deshpande et al. 2009). Therefore in the 
present work a number of QSAR models were generated utilizing topological, functional 
group and atom centered fragments, constitutional and molecular property descriptors, 
respectively. Impact of different types of descriptors on antimalarial activities is focused 
in terms of R2 and its validation is done by calculating cross-validated R2 (R2cv) while 
treating the data set using MLR coupled with stepwise forward–backward selection 
methods. Outcomes were given in the following Table 3.
The above MLR models described that topological indices can produce highest influ-
ences in terms of R2 and R2cv calculated as 0.870 and 0.810 followed by functional group 
and atom centered fragments, constitutional and molecular property, 3D and geomet-
rical indices, respectively, which can contribute moderate impact on the inhibition of 
P. falciparum parasitic strain. Therefore, in the next attempt, topological indices have 
been selected to develop a number of QSAR models which are validated statistically 
by incorporating training and test sets concept as well as external validations. External 
validations are carried out by calculating predicted R2 and rm2 respectively. Topological 
descriptor based best training QSAR model, along with its quality and interpretation of 
modeled parameters are explained in the following Table 4. Predicted R2 and rm2 are cal-








Table 3 Impact of descriptors on biological activity
Descriptor class R2 R2cv
Topological 0.870 0.810
Functional group + atom centered fragments 0.812 0.744
Constitutional + molecular property 0.784 0.644
3d + geometrical 0.713 0.634
Page 10 of 20Parihar and Nandi  SpringerPlus  (2015) 4:819 
where, Ypred(test) and Y(test) indicate predicted and observed activity values respectively 
of the test set compounds and Y¯ training indicates mean of observed activity values of the 
training set. For a predictive QSAR model, the value of R2pred should be more than 0.5 
(Nandi and Bagchi 2011a, b).
Further, external predictability of the generated QSAR models was scrutinized by cal-
culating modified r2 (rm2 ), average modified r2 (r2m) and delta modified r2 (∆rm2 ), respec-
tively which are given as
where, r2 and ro2 are squared correlation coefficient between the observed (Y axis) and 
predicted (X axis) activity values of the test set with and without intercept, respectively. 
rm2 value must be greater than 0.5 to have a significant model (Roy and Roy 2008, 2009; 
Roy et al. 2013). Change of the axes gives the value of r′02 and r′m2 is calculated by the fol-
lowing formula which depends on the value of r′02.
where, r2 and r′02 are squared correlation coefficient between the observed (X axis) and 
predicted (Y axis) activity values of the test set with and without intercept, respectively. 





































Table 4 Topological indices based training QSAR model and interpretation of the modeled 
descriptors
Validated training QSAR model
pIC50 = (−10.234) + (−9.3) ∗ BIC5 + (−1.83) ∗ GATS7e + (−3.19) ∗MATS7e + (4.81) ∗ BEHe4













= 0.04, SEE = 0.282
Modeled descriptors Interpretation
BIC5 Bond information content index (neighborhood symmetry of 5-order)
GATS7e Geary autocorrelation—lag 7/weighted by atomic Sanderson electronegativities. 2D 
autocorrelations
MATS7e Moran autocorrelation—lag 7/weighted by atomic Sanderson electronegativities
BEHe4 Highest eigen value of number 4 of burden matrix/weighted by atomic Sanderson 
electronegativities
EEig12r Eigenvalue 12 from edge adj. matrix weighted by resonance integrals
DP12 Molecular profile number 12
BELm7 Lowest eigenvalue number 7 of Burden matrix/weighted by atomic masses
PCR ratio of multiple path count over path count
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It is noticeable that an acceptable QSAR model should give the value of “Average 
rm2” > 0.5 and “Delta rm2” should be <0.2, respectively. Values of modified r2 (rm2 ), average 
rm2 (r2m) and delta rm2 (∆rm2 ) have been efficiently computed by web free software link of 
http://aptsoftware.co.in/ rmsquare/and http://203.200.173.43:8080/rmsquare/, respec-
tively (Roy et al. 2013).
The selected model can explain and predict 87 and 81 % of variances of the antima-
larial activity of the deliberated compounds. This model can also produce 73.7 % exter-
nal predictability and rm2 value of 0.659 whereas values of average rm2 of 0.682 and delta rm2 
of 0.04 extend more efficient evidence of external predictability of the generated QSAR 
model. Further the above QSAR model is confirmed its external predictability by pre-
dicting the response activities of the test molecules, as specified in Table 5.
From the Table 5 it is obvious that the predicted responses of all the test compounds are 
in good treaty with their corresponding observed responses and ideal fit is attained pro-
duced by plotting a graph (Fig. 1) by correlating observed activity versus predicted activ-
ity of the test set compounds. The squared correlation coefficient is calculated as 0.771.
Once the QSAR model formulated and validated properly, its utility is to predict the 
biological responses of the compounds which are generated by combinatorial deign and 
experimentally non-investigated.
Table 5 Predicted activity for the test set molecules

























Fig. 1 Observed versus predicted activities of the test molecules
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Combinatorial library generation and virtual screening
In the present study a total number of 2160 compounds have been generated by intro-
ducing a number of 10, 4, 9 and 6 different substituents at various substitution points 
including R3′, R4′, R5′ and R7′, respectively connected to the common template of 4-ani-
linoquinoline. The rationale behind this group selection is to undergo literature sur-
vey to find out the active lead in these congeners including amodiaquine and isoquine 
respectively (O’Neill et al. 2003). Let us consider the different functional groups associ-
ated to the scaffold of these lead compounds and modify these substituents based on the 
developed pharmacophore model for active lead. The special feature of the new family 
reported here are the presence of basic side chain at both the 3′ and 5′ positions and 
therefore the impossibility of nucleophillic addition of proteins even in the case of a met-
abolic hydroxylation at the hindered 4′-site (Delarue et al. 2001). R4′ position should be 
substituted by bio-isosteres of –OH group whereas electron drawing moiety is favorable 
at R7 position of the common substructure.
All the optimized virtual compounds were screened by predicting biological activities 
in terms of pIC50 utilizing best topological indices based training QSAR model described 
in Table 4. As per the prediction, a number of top 16 highly predicted active compounds 
(Table 6) were reported as hits for further lead optimization process. It was shown that 
predicted activity of all these 16 highly active virtual hits much greater than the AQ lead. 
It was also calculated that these highly predicted active virtual compounds match with 
the property ranges as prescribed by Lipinski’s ‘Rule of Five’ which include following 
properties such as number of hydrogen bond acceptor, number of hydrogen bond donor, 
XlogP, molecular weight and rotatable bond count respectively.
As none of these virtual compounds are experimentally tested, it is very vital to test 
whether these compounds are within the chemical applicability domain (AD) of the 
developed model, especially in view of that all 16 hit molecules have biological activity 
values much higher than those of the training set compounds (i.e., the hit compounds 
are outside the activity domain of the training molecules). The applicability domain 
of a training QSAR model determines its acceptance by the regulatory bodies such as 
Organization for Economic Cooperation and Development (OECD) for its applications 
to predict new molecules. The OECD Principle 3 defines ‘a defined domain of applicabil-
ity’ for the developed QSAR model. The Setubal Workshop report (Jaworska et al. 2005) 
presented the following regulation for the AD assessment: “The applicability domain of 
a (Q)SAR is the physico-chemical, structural, or biological space, knowledge or informa-
tion on which the training set of the model has been developed, and for which it is appli-
cable to make predictions for new compounds. The applicability domain of a (Q)SAR 
should be described in terms of the most relevant parameters, i.e., usually those that are 
descriptors of the model. Ideally the (Q)SAR should only be used to make predictions 
within that domain by interpolation not extrapolation” (OECD 2007).
In the present study, applicability domain of the training model as well as top 16 virtual 
4-anilino quinolone hits were calculated by using “AD using Standardization approach” 
which is a free ware tool (Roy et al. 2015a, b, c) to find out whether query compounds are 
located outside the applicability domain of the built QSAR model and it also detects out-
liers present in the training set compounds. The results depicted that training molecules 
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1 and 19 were detected as outlier whereas all the predicted hits are situated within the 
zone of AD.
Further, to cross check the accuracy of this model validation, leverage value (h) and 
warning leverage (h*) for each of screened hits were calculated. The leverage value (h) 
of a compound in the original variable space which measures its influence on the model 
may be defined as
where, xi is the descriptor row-vector of the i-th compound, xiT is the transpose of xi, X 
is the descriptor matrix, XT is the transpose of X (XTX)−1 is the inverse of matrix XTX.
 where, n is the number of training compounds and k is the number of model parameters 
(Hong et al. 2009; Hemmateenejad and Yazdani 2009; Nandi et al. 2011). The leverage 
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value is of 0.480. A leverage (h) greater than warning leverage (h*) means that the pre-
dicted response is the result of substantial extrapolation of the model and therefore may 
not be reliable. For the present investigation, it was observed that the leverages of all hit 
compounds are lower than h* which are pretty acceptable.
Further lead optimization through pharmacophore modeling
Finally, 16 compounds were predicted as promising 4-anilinoquinoline hits active 
against chloroquine resistant P. falciparum FcB1R strain. As the crystal structure of the 
P. falciparum target is unknown, therefore, the predicted hits were subjected to phar-
macophore generation to investigate the mode of interaction with the receptor target. 
Fully optimized 3D structure of AQ was considered as a reference for pharmacophore 
generation because AQ is an established potential lead-like drug in this in 4-anilinoqui-
noline congeneric series. To focus the inhibitor’s crucial features required for binding 
with malarial P. falciparum FcB1R strain, a comparative study between the amodiaquine 
(lead) and 4-anilinoquinoline (highly active virtual compounds) pharmacophore has 
been studied. The pharmacophore model generated by us for amodiaquine (lead) is 
given in Fig. 2.
The above model predicted five features including three aromatic points (blue circle), 
six hydrophobicity (yellow ball), two HBAs (orange color), two HBDs (green arrow and 
lawn green ball) and one positive ionization (blue star). Quinoline nucleus itself should 
be aromatic and hydrophobic. N1 of the quinoline is a hydrogen bond acceptor whereas 
4-amino group is hydrogen bond donor. 4-anilino benzene contributes aromaticity. R3′ 
may interact with the target by creating hydrophobicity and positive ionization. R4′ can 
produce hydrogen bond interaction. Electron withdrawing moiety is favorable at R7 
position of the quinoline nucleus which is also responsible for producing hydrophobic 
interaction.
The detailed comparative pharmacophoric 3D features for AQ (lead) and top 16 pre-
dicted active congeners have been given in the following Table 7.
For AQ lead and rest of the highly predicted active compounds considered by us 
after screening (Table 7), it is seen that the aromatic quinoline ring should interact with 
hydrophobic residues. N1 of the quinoline, 4-amino and R4′ of the aniline moiety may 
produce hydrogen bond interactions. 4-anilino benzene shows aromaticity. R7 posi-
tion of the quinolone interacts with hydrophobic residues whereas R3′ and R5′ must be 
Fig. 2 Pharmacophore of amodiaquine (AQ)
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substituted by the groups which contribute positive ionizations responsible for ligand 
receptor interactions. Therefore this is an important attempt for prediction of bio-
chemical mechanisms of the top virtual hits generated by combinatorial library design. 
Although experimental validation of the screened hits are necessary utilizing in vitro and 
in vivo analyses, however, an integration of pharmacophore modeling, virtual screening, 
structure-based methods, molecular biology and combinatorial chemistry together can 
provide a better basis for more efficient drug discovery and design reducing both costs 
and time.
New focus on compound’s mechanism of action
When the pharmacophore models developed for screened highly active combinatorial 
hits (Figs. 3, 4) were compared with the AQ lead, a significant comparable performance 
was noted in terms of mode of interactions with the target protein. As per the predic-
tion, compound ID 659 and 649 were predicted as highest active hits with predicted 
activities (pIC50) are 4.943 and 4.919 µM respectively. The pharmacophoric interaction 
patterns of selected active hits were shown in Figs. 3 and 4. Some more active virtual hits 
were predicted as ID 454, 464, 444, 597 and 577 of those modes of binding and predicted 
activity are likely with compound ID 659 and 649.
The predicted activities of these two compounds and mode of bindings are almost 
similar, there is a sharp change in pharmacophore when compared with AQ lead and 
the other two compounds. From the pharmacophore models (Figs. 3, 4) it is clear that 
R3′ and R5′ must be substituted by the basic groups containing tertiary amino moiety 
responsible for producing positive ionization (PI). More PI in these regions can increase 
affinity of the ligand towards negative environment of the acidic parasitic digestive 
Table 7 Comparative pharmacophoric 3D features for  AQ (lead) and  top 16 predicted 
active congeners
H hydrophobicity, AR aromaticity, HBD hydrogen bond donor, HBA hydrogen bond acceptor, PI positive ionization
Compound ID Pharmacophoric 3D features predicted by our models
Quinoline N1 4-amino 4-anilino benzene R7 R′3 R′4 R′5
AQ (Lead) H; AR HBA HBD AR H PI; H HBA; HBD -
659 H; AR HBA HBD AR H; HBA PI HBA;HBD PI
649 H; AR HBA HBD AR H; HBA PI HBD PI
289 H; AR HBA HBD AR H PI HBD PI
299 H; AR HBA HBD AR H PI HBA;HBD PI
1029 H; AR HBA HBD AR H PI HBA;HBD PI
1009 H; AR HBA HBD AR H PI HBD PI
1019 H; AR HBA HBD AR H PI HBA;HBD PI
403 H; AR HBA HBD AR H; HBA PI HBD PI
454 H; AR HBA HBD AR H; HBA PI; H; H HBA;HBD PI; H; H
413 H; AR HBA HBD AR H; HBA PI HBA;HBD PI
464 H; AR HBA HBD AR H; HBA PI; H; H HBA;HBD PI; H; H
444 H; AR HBA HBD AR H; HBA PI; H; H HBD PI; H; H
340 H; AR HBA HBD AR H AR; H; H HBA;HBD AR; H; H
597 H; AR HBA HBD AR H; HBA PI; H; H HBA; H; AR PI; H; H
577 H; AR HBA HBD AR H; HBA PI; H; H HBA;HBD PI; H; H
43 H; AR HBA HBD AR H PI HBD PI
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vacuoles. R7 electron withdrawing moiety of quinoline may produce hydrogen bond 
interaction with the target protein. These added pharmacophoric features in compare 
with AQ (lead) pharmacophore may enhance the antimalarial activity of these com-
pounds. The special feature of the new family already reported is the presence of a basic 
side chain at both the R3′ and R5′ positions and therefore the impossibility of nucleophil-
lic addition of proteins even in the case of a metabolic hydroxylation at the hindered R4′ 
site (Delarue et al. 2001). Metabolic hydroxylation of R4′ substituent may produce toxic 
metabolite (O’Neill et al. 2003). To generate least toxic and highly active compounds an 
attempt has been made in the current study for the designing of 4-anilinoquinoline com-
pounds by substituting thiol, diazo, phenyl diazo and amino groups instead of hydroxyl 
group.















Fig. 3 Pharmacophore models of selected highly active virtual hits
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Conclusion and future direction
The advance research, so far yet, focused that 4-anilinoquinolines are basic in nature. 
They can deposit into the acidic digestive vacuoles of the plasmodium and interact 
with the heme and interfere with the parasitic DNA sequestration (Valderramos and 
Fidock 2006). From the present study of pharmacophore modeling, it has been found 
that tertiary amino group (basic) associated with R3′ and R5′ positions impart positive 
ionizations. Parasitic nucleic acid bases such as quinine and uracil may undergo nucleo-
phillic attack. The tert-N-group of the compound may interact with this guanine and 
uracil bases via positive ionization and thus breaks the DNA chain length of the malar-














ID Structure of pharmacophore ID Structure of pharmacophore 
Fig. 4 Pharmacophore models of selected highly active virtual hits
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hydrophobicity and cause hydrophobic interaction with the hydrophobic amino acid res-
idues such as histidine of the parasitic proteins. Heme is bound with histidine and lipid 
to undergo DNA sequestration. Thus positive charge ionization and hydrophobicity are 
responsible to inhibit DNA sequestration. Therefore the virtual compounds ID including 
454, 464, 444, 597 and 577 are predicted as highly active hits in this congeneric series. 
Compounds ID 659 and 649 are predicted as highest top two active lead like compounds 
because R7 electron withdrawing moiety of these compounds may contribute an addi-
tional hydrogen bond interaction which is decisive for producing antimalarial activity. 
In comparison to AQ lead, other predicted active hits ID including 289, 299, 1029, 1009, 
1019, 340 and 43 bear almost same mode of pharmacophoric interaction patterns with 
an additional feature of PI at R5′ position. Therefore, these predicted active virtual com-
pounds may be recommended for further synthesis and testing as potent agents against 
P. falciparum FcB1R strain. Studies in this direction may help to design new congeneric 
active leads with least toxicity. Further, synthesis, testing for activity and toxicity study 
may be carried out in near future to model potent antimalarial compounds in this series.
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